Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Senior V. P., Operations | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.2033 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.2033 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.1949 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.1949 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.5014 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 1.6351 · Balance 13.5014 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 14.774 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.9599 · Balance 14.774 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 12.2651 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 2.1927 · Balance 12.2651 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.0157 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 2.4831 · Balance 13.0157 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 9.4928 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 3.6735 · Balance 9.4928 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2024 Filed Mar 5, 2024 01:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006504 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006504 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,189 F1 · shares: These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · derivative · entry 8 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.6411 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 49 | $54.85 | $2,687.65 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · nonDerivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,997 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F2 · price: Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 79 | $56.06 | $4,428.74 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,043 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035158 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034357 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.0336 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 89 | $53.81 | $4,789.09 |
DisclosureSEC source: 0001437749-23-034357 · rdgdoc.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,113 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034357 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034357 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.9269 Underlying: Common Stock · 6 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 89 | $54.40 | $4,841.60 |
DisclosureSEC source: 0001437749-23-034357 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,199 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034357 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 5,398 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001437749-23-034238 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,398 Underlying: Common Stock · 5,398 shares Expires 2030-12-08 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034238 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,282 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033649 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.3835 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033649 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.19 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033496 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.03 Underlying: Common Stock · 3.19 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.3508 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033496 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19.93 Underlying: Common Stock · 2.3508 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2587 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033496 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.38 Underlying: Common Stock · 1.2587 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8856 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033496 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.64 Underlying: Common Stock · 0.8856 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6708 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033496 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.84 Underlying: Common Stock · 0.6708 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.9012 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025183 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.84 Underlying: Common Stock · 2.9012 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1373 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025183 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.58 Underlying: Common Stock · 2.1373 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.1441 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025183 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.12 Underlying: Common Stock · 1.1441 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.805 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025183 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.76 Underlying: Common Stock · 0.805 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6098 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025183 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.16 Underlying: Common Stock · 0.6098 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.6068 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016636 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.9424 Underlying: Common Stock · 2.6068 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.9158 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016636 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.4388 Underlying: Common Stock · 1.9158 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0258 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016636 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.9807 Underlying: Common Stock · 1.0258 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7218 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016636 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.9505 Underlying: Common Stock · 0.7218 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.5468 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016636 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.5544 Underlying: Common Stock · 0.5468 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.3356 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007970 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.3356 Underlying: Common Stock · 3.3356 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.4513 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007970 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.523 Underlying: Common Stock · 2.4513 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.3123 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007970 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.9549 Underlying: Common Stock · 1.3123 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9234 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007970 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.2287 Underlying: Common Stock · 0.9234 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6996 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007970 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.0076 Underlying: Common Stock · 0.6996 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 81 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-23-005807 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,331 Underlying: Common Stock · 81 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,008 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-23-005807 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,018 Underlying: Common Stock · 2,008 shares Expires 2025-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 81 | $35.48 | $2,873.88 |
DisclosureSEC source: 0001437749-23-005807 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,008 | $23.56 | $47,308.48 |
DisclosureSEC source: 0001437749-23-005807 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,592 | $31.30 | $49,829.60 |
DisclosureSEC source: 0001437749-23-005807 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 6,414 | $50.94 | $326,739.42 |
DisclosureSEC source: 0001437749-23-005527 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,791 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.65 to $61.18 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 22, 2022 Filed Dec 28, 2022 02:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 54 | $45.94 | $2,480.76 |
DisclosureSEC source: 0001437749-22-029820 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,031 F1 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 02:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-029561 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7.3053 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 02:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 51 | $46.46 | $2,369.46 |
DisclosureSEC source: 0001437749-22-029561 · rdgdoc.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,085 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 02:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-029561 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.